1st Quarter - Termination
KRAMERICH POLICY STRATEGIES for TAYLOR STRATEGIES ON BEHALF OF PTC THERAPEUTICS
Income
$20,000
Expenses
—
Terminated
Feb 28, 2019
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Seeking drug approval through the FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE KRAMERICH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.